Jane P Jensen

Title: Jane P Jensen: Innovator in Pharmaceutical Compounds

Introduction

Jane P Jensen is a notable inventor based in Gettysburg, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target cancer and viral infections. With a total of 2 patents, her work has the potential to impact the medical community significantly.

Latest Patents

Jensen's latest patents include innovative compounds and methods for treating patients. The first patent, titled "Inhibitors of Ubiquitin E1," features pyrazolidinyl compounds and pharmaceutical compositions designed to treat patients suffering from cancer or viral infections. The method involves administering one or more pyrazolidinyl compounds to the patient. The second patent, "Deazaflavin Compounds and Methods of Use Thereof," focuses on 5-deazaflavin compounds and their pharmaceutical compositions, also aimed at treating cancer patients through similar administration methods.

Career Highlights

Throughout her career, Jane P Jensen has worked with prominent organizations, including the United States of America, as represented by the Secretary, Department of Health and Human Services, and Bioveris Corporation. Her work in these institutions has allowed her to contribute to significant advancements in pharmaceutical research.

Collaborations

Jensen has collaborated with esteemed colleagues such as Allan M Weissman and Yili Yang. These partnerships have likely enriched her research and development efforts, leading to her successful patent applications.

Conclusion

Jane P Jensen's innovative work in pharmaceutical compounds showcases her dedication to improving treatment options for patients with serious health conditions. Her contributions through her patents reflect her commitment to advancing medical science and enhancing patient care.